Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system

Pharmacology & Therapeutics
Joanne Y T LeungCatherine C Y Pang

Abstract

Cardiovascular disease is the leading cause of death in people with severe mental disorders, and rates are proportionally greater than for other diseases such as cancer. Reports of sudden death in patients receiving antipsychotic treatment have raised concerns about the safety of antipsychotic drugs, leading to a number of recent changes in how such drugs are advertised and marketed. The majority of second generation antipsychotic drugs also have significant metabolic side-effects, such as weight gain, insulin resistance and hyperlipidemia, which may contribute indirectly to cardiovascular complications. As the use of antipsychotic drugs continues to expand into new indications and populations such as children and adolescents, a better understanding is needed of how antipsychotic drugs affect the cardiovascular system. Antipsychotic drugs interact with numerous receptors both centrally and peripherally, including monoamine receptors. The direct, non-specific pharmacological actions of antipsychotic drugs can lead to adverse cardiovascular effects, including orthostatic hypotension, tachycardia and ventricular arrhythmias. The mechanisms responsible for these antipsychotic-induced cardiovascular abnormalities have not been fully...Continue Reading

References

Jan 1, 1989·Psychopharmacology·H J GaertnerJ Hoss
Jan 1, 1983·Journal of Neural Transmission·A PerringtonM J Christie
Oct 1, 1982·Archives of General Psychiatry·S CastellaniC R Lake
Nov 1, 1993·British Journal of Anaesthesia·P AnnilaL Lindgren
Apr 1, 1996·Acta Psychiatrica Scandinavica·J P WarnerJ A Henry
Jan 1, 1997·Journal of Neural Transmission·E SchulzH Remschmidt
Dec 24, 1998·Journal of Clinical Psychopharmacology·M D DriciD A Flockhart
Apr 15, 1999·Clinical Neuropharmacology·B SpivakA Weizman
Sep 10, 1999·Journal of Reconstructive Microsurgery·A C AygitI Yildirim
Dec 10, 1999·Lancet·J G KilianD S Celermajer
Jun 1, 2000·Journal of Clinical Psychopharmacology·K N ChengappaR A Zoretich
Jun 1, 2000·The American Journal of Psychiatry·D C HendersonD C Goff
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·N A Buckley, P Sanders
May 19, 2001·BMJ : British Medical Journal·D M CoulterI R Edwards
Jul 21, 2001·The New England Journal of Medicine·L La GrenadeA Trontell
Aug 4, 2001·The Annals of Pharmacotherapy·J D HoehnsK B Tu
Apr 3, 2002·Archives of General Psychiatry·John W NewcomerGregg Selke
Jun 4, 2002·The British Journal of Psychiatry : the Journal of Mental Science·J G ReillyS H L Thomas
Jul 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Igor ElmanAlan Breier
Aug 31, 2002·The American Journal of Psychiatry·Daniela Roesch-ElyMatthias Weisbrod
Nov 5, 2002·Depression and Anxiety·Michael Mueck-WeymannDominique Musselman
Dec 31, 2002·Journal of Psychopharmacology·B SilkeD J King
Feb 26, 2003·European Journal of Pharmacology·Maarten van den Buuse
May 31, 2003·Journal of Cardiovascular Pharmacology·Benoit DroletJacques Turgeon
Dec 1, 1964·British Journal of Pharmacology and Chemotherapy·S D GOKHALEH M PARIKH
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frank P BymasterDavid L Mckinzie
Feb 26, 2004·Obesity Research·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Apr 9, 2004·Journal of Cardiovascular Pharmacology·So-Young LeeSu-Hyun Jo
May 28, 2004·The Journal of Clinical Psychiatry·David C HendersonDoug Hayden
Nov 24, 2004·The Australian and New Zealand Journal of Psychiatry·Jonathan ReindersSally Plever
Jan 27, 2005·QJM : Monthly Journal of the Association of Physicians·M J ReedP S Addison
Jun 21, 2005·The International Journal of Neuropsychopharmacology·Eva LindströmWilhelm Haverkamp

❮ Previous
Next ❯

Citations

Nov 28, 2013·Pharmacogenomics·Amy C C Kao, Daniel J Müller
Jun 28, 2014·Vascular Pharmacology·Joanne Y T LeungAlasdair M Barr
Dec 24, 2013·Future Medicinal Chemistry·Pawel ZajdelAnna Wesolowska
Oct 10, 2013·BMC Psychiatry·David LintonAlasdair M Barr
Jul 19, 2013·Current Cardiovascular Risk Reports·Donna J LangRic M Procyshyn
Jan 1, 2013·Drug and Alcohol Dependence·William J PanenkaAlasdair M Barr
Feb 15, 2013·Obesity·Xingsheng LiTim R Nagy
Mar 5, 2016·Expert Opinion on Drug Safety·Christoffer PolcwiartekJimmi Nielsen
Dec 30, 2014·Cardiovascular Toxicology·Basel A Abdel-Wahab, Metwally E Metwally
Oct 22, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Heidi N BoydaAlasdair M Barr
Apr 18, 2016·Journal of Pharmacological and Toxicological Methods·Matthew R ZahnerChris J Somps
Aug 2, 2012·Expert Opinion on Pharmacotherapy·Frank I Tarazi, Stephen M Stahl
Apr 14, 2015·Expert Opinion on Pharmacotherapy·Jan Malte BumbF Markus Leweke
Feb 3, 2015·Annals of Emergency Medicine·Ingrid Berling, Geoffrey K Isbister
Mar 25, 2015·Journal of Child and Adolescent Psychopharmacology·Zachary WhitneyAlasdair M Barr
Jan 30, 2015·European Journal of Clinical Pharmacology·Z WhitneyA M Barr
Aug 21, 2013·The International Journal of Neuropsychopharmacology·H N BoydaA M Barr
Dec 9, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·M-L MenardD Cohen
May 26, 2016·Hospital Practice·Vicente Cés Souza-DantasJorge Salluh
Jun 21, 2016·Journal of the American Geriatrics Society·Marit S BakkenSabine Ruths
May 10, 2017·Journal of Clinical Psychopharmacology·Matt Perdue, Tim Botello
Jul 25, 2014·Therapeutic Advances in Psychopharmacology·John LallyJames H MacCabe
Sep 8, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·T Scott Stroup, Neil Gray
Aug 11, 2017·Journal of Clinical Psychopharmacology·Arduino A MangoniRichard J Woodman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.